Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-05-24T02:24:21.217Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence of COVID-19 in West Gondar Zone, Northwest Ethiopia: A Population-Based Retrospective Study

Published online by Cambridge University Press:  23 March 2022

Tiruneh Adane Open the ORCID record for Tiruneh Adane [Opens in a new window] ,
Yonnas Adugna  and
Melak Aynalem
Tiruneh Adane*
Affiliation:
Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
Yonnas Adugna
Affiliation:
Department of Environmental and Occupational Health & Safety, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
Melak Aynalem
Affiliation:
Department of Hematology and Immunohematology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
*
Corresponding author: Tiruneh Adane, Email: tirunehadane01@gmail.com.
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Coronavirus disease 2019 (COVID-19) has spread rapidly around the world, affecting every community directly or indirectly. Therefore, this study aims to investigate the prevalence of COVID-19 infection in the population of the West Gondar zone.

Method:

A retrospective cross-sectional study was conducted from November 2020 to January 2021, in the West Gondar zone, Northwest Ethiopia. Records of study participants with required information like age, gender, travel history, type of specimen taken, and site of specimen taken were included. For analysis, the statistical package for social sciences (SPSS) version 20 software was used. Descriptive statistics were summarized as percentages and means ± standard deviation. The chi-squared test is used to compare categorical data.

Results:

A total of 1,166 participants were enrolled in this study. Of them, 16 individuals had positive results, giving a prevalence of 1.37% (95% CI: 0.66-2.08). Living in an urban area (P-value = 0.035) and being female (P-value = 0.045) was statistically associated with the positive rate for COVID-19.

Conclusions:

This study revealed a low prevalence of COVID-19 infection in the study area despite the increasing and rapid dissemination of the disease. State-wide population prevalence study should be done to estimate the general prevalence of COVID-19 in Ethiopia.

Keywords

community based surveillanceCOVID-19West GondarEthiopia
Type
Original Research
Information
Disaster Medicine and Public Health Preparedness , Volume 17 , 2023 , e156
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rothan, HA, Byrareddy, SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.CrossRefGoogle ScholarPubMed
Vodičar, PM, Valenčak, AO, Zupan, B, et al. Low prevalence of active COVID-19 in Slovenia: a nationwide population study of a probability-based sample. Clin Microbiol Infect. 2020;26(11):1514-1519.CrossRefGoogle Scholar
Assiri, A, Al-Tawfiq, JA, Al-Rabeeah, AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752-761.CrossRefGoogle ScholarPubMed
Baye, K. COVID-19 Prevention Measures in Ethiopia: Current Realities and Prospects. Vol. 141: International Food Policy Reserch Institute; 2020.CrossRefGoogle Scholar
Shigute, Z, Mebratie, AD, Alemu, G, et al. Containing the spread of COVID-19 in Ethiopia. J Glob Health. 2020;10(1):010369.CrossRefGoogle ScholarPubMed
World Health Organization. Surveillance strategies for COVID-19 human infection: interim guidance May 10, 2020. World Health Organization; 2020.Google Scholar
Guerra, J, Acharya, P, Barnadas, C. Community-based surveillance: a scoping review. PLoS One. 2019;14(4):e0215278.CrossRefGoogle ScholarPubMed
World Health Organization. Integrated disease surveillance and response in the African region-a guide for establishing community based surveillance. WHO Regional Office for Africa; 2014.Google Scholar
Gomes, CC, Cerutti, C, Zandonade, E, et al. A population-based study of the prevalence of COVID-19 infection in Espírito Santo, Brazil: methodology and results of the first stage. medRxiv. 2020. doi: https://doi.org/10.1101/2020.06.13.20130559 Google Scholar
World Health Organization. Public health surveillance for COVID-19: interim guidance December 16, 2020. World Health Organization; 2020.Google Scholar
Tadesse, EB, Endris, AA, Solomon, H, et al. Seroprevalence and risk factors for SARS-CoV-2 infection in selected urban areas in Ethiopia: a cross-sectional evaluation during July 2020. Int J Infect Dis. 2021;111:179-185.CrossRefGoogle Scholar
Abdella, S, Riou, S, Tessema, M, et al. Prevalence of SARS-CoV-2 in urban and rural Ethiopia: randomized household serosurveys reveal level of spread during the first wave of the pandemic. EClinicalMedicine. 2021;35:100880.CrossRefGoogle Scholar
Population Census Commission. Summary and Statistical Report of the 2007 Population and Housing Census: Population Size by Age and Sex. Federal Democratic Republic of Ethiopia; 2008.Google Scholar
World Health Organization. Global surveillance for human infection with novel coronavirus (2019-nCoV): interim guidance January 21, 2020. World Health Organization; 2020.Google Scholar
World Health Organization. Global COVID-19: clinical platform: novel coronavius (COVID-19): rapid version. World Health Organization; 2020.Google Scholar
World Health Organization. Population-based age-stratified seroepidemiological investigation protocol for COVID-19 virus infection March 17, 2020. World Health Organization; 2020.Google Scholar
Menachemi, N, Yiannoutsos, CT, Dixon, BE, et al. Population point prevalence of SARS-CoV-2 infection based on a statewide random sample—Indiana, April 25-29, 2020. MMWR Morbid Mortal Wkly Rep. 2020, 69(29):960.CrossRefGoogle ScholarPubMed
Geto, Z, Gebremichael, S, Belete, MA, et al. The escalating magnitude of COVID-19 infections among the Northeastern Ethiopia Region: a community-based cross-sectional study. Int J Microbiol. 2021;2021:5549893.CrossRefGoogle ScholarPubMed
Gudina, EK, Gobena, D, Debela, T, et al. COVID-19 in Oromia Region of Ethiopia: a review of the first 6 months’ surveillance data. BMJ Open. 2021;11(3):e046764.CrossRefGoogle Scholar
Sood, N, Simon, P, Ebner, P, et al. Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles County, California, on April 10-11, 2020. JAMA. 2020;323(23):2425-2427.CrossRefGoogle ScholarPubMed
Gudbjartsson, DF, Helgason, A, Jonsson, H, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med. 2020;382(24):2302-2315.CrossRefGoogle ScholarPubMed
Kejela, T. Probable factors contributing to the fast spread of the novel coronavirus (COVID-19) in Ethiopia. J Infect Dis Epidemiol. 2020;6:169.Google Scholar
Bankole, TO, Omoyeni, OB, Oyebode, AO, et al. Low incidence of COVID-19 in the West African sub-region: mitigating healthcare delivery system or a matter of time? J Public Health. 2020:1-10.Google ScholarPubMed
Conti, P, Younes, A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J Biol Regul Homeost Agents. 2020;34(2):339-343.Google ScholarPubMed
Pan, A, Liu, L, Wang, C, et al. Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA. 2020;323(19):1915-1923.CrossRefGoogle ScholarPubMed
Gebretsadik, D, Ahmed, N, Kebede, E, et al. Knowledge, attitude, practice towards COVID-19 pandemic and its prevalence among hospital visitors at Ataye district hospital, Northeast Ethiopia. PLoS One. 2021;16(2):e0246154.CrossRefGoogle ScholarPubMed
Bhatta, S, Gandhi, S, Saindani, SJ, et al. Otorhinolaryngological manifestations of coronavirus disease 2019: a prospective review of 600 patients. The Journal of Laryngology & Otology. 2021;135(3):206-211.CrossRefGoogle ScholarPubMed
Eregata, GT, Hailu, A, Memirie, ST, et al. Measuring progress towards universal health coverage: national and subnational analysis in Ethiopia. BMJ Glob Health. 2019;4(6):e001843.CrossRefGoogle ScholarPubMed
Alene, KA, Gelaw, YA, Fetene, DM, et al. COVID-19 in Ethiopia: a geospatial analysis of vulnerability to infection, case severity and death. BMJ Open. 2021;11(2):e044606.CrossRefGoogle Scholar